US 2010/0063129 A9Published application

Metabolites of wortmannin analogs and methods of using the same

AssigneeThe Arizona Board of Regents Acting on Behalf of the University of Arizona

InventorGarth Powis

Life of this patent

Estimating the term…

Abstract

Novel metabolites of wortmannin and wortmannin analogs and their use in inhibiting PI-3 kinase activity in mammals and the treatment and prevention of cancer or tumor formation in a subject are described herein.

Claims8

Dependent claims

A compound of the formula:

Dependencies are inferred from the claim text.

Facts

Application: 11/618,036Filed 29 Dec 2006
Priority: 9 Jul 2004
Published: 11 Mar 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07D 311/94
Ortho- or peri-condensed with carbocyclic rings or ring systems: condensed with rings other than six-membered or with ring systems containing such…
A61P 35/00
Antineoplastic agents
C07D
Heterocyclic compounds
A61P
Therapeutic uses of medicines

Family

Application60/586,687Us provisional application · filed 9 Jul 2004
Application11/178,553Continuation in part · filed 11 Jul 2005
Application60/755,477Us provisional application · filed 30 Dec 2005
Application11/618,036Continuation in part · filed 29 Dec 2006
US 2006/0063824 A1Published application
US 2007/0191466 A1Published application
US 7,446,124 B2Related patent
US 7,723,375 B2Related patent
US 2010/0063129 A9This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results